HER2/Neu-negative Carcinoma of Breast
1 clinical trials · Condition
◉ Watch HER2/Neu-negative Carcinoma of Breast
| Record | Firm | Date |
|---|---|---|
| Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab (NCT02248571) | iOMEDICO AG | 2014-08-01 |
Track HER2/Neu-negative Carcinoma of Breast automatically
Every clearance here is in the API, with alerts when new ones post.